Patient-Centered Decision Support for Eosinophilic Esophagitis
ConditionEosinophilic Esophagitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan
About this trial
The study team is conducting this project to learn more about how patients with eosinophilic esophagitis (EoE) like to use and receive educational materials about treatment options and treatment decision making.
This study will assess the efficacy of a decision support intervention to make decisions about treatment and disease management for patients with EoE and will assess the feasibility and acceptability of the intervention to inform future R01-level studies.
The study team hypothesize that deploying the intervention will be feasible, and it will demonstrate high acceptability among EoE patients. Additionally, that patients that use the intervention (vs general education about EoE) will report greater treatment knowledge, increased readiness to choose a therapy, adherence to therapy, and follow-up.
Eligibility criteria
Qualifiers
New EoE patient evaluations ≥18 years old at University of Michigan (UM) that have an upcoming outpatient visit in a UM-gastroenterology or allergy & immunology clinic,
Able to speak and read English.
Disqualifiers
Prisoners and institutionalized individuals due to logistical limitations for use of a web app and follow-up interactions in these populations.
Patients that have significant cognitive or visual impairment that limits interaction with the decision aid (DA)
Patients that are terminally ill
Patients that do not have an email address or reliable access to the internet
Trial design
Treatments tested in this trial
- General education control
- Decision support tool
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Michigan
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov